Molecular diagnostics refers to the use of molecular alterations that are associated with cancers to facilitate detection, diagnosis, monitoring, and/or treatment. Molecular biomarkers have often been studied in cancer tissue but potentially can be assayed in readily available patient samples (saliva, ...
国际期刊Frontiers in Molecular Biosciences(最新影响因子4.188)”Molecular Diagnostics and Therapeutics” 栏目正在征稿,研究主题“Molecular Biomarkers for the Diagnosis, Prognosis, and Risk Prediction of Cancer(癌症诊断、预后和风险预测的...
Using non-invasive liquid biopsy diagnostics to detect mRNA cancer biomarkers, analyze them with AI-enabled bioanalytics, and provide oncologists with precise diagnostic and treatment information. Harnessing research for advanced diagnostics Revolutionizing Cancer Diagnostics with novel liquid biopsy mRNA Techn...
cancermetabolite profilingmetabolomicsmolecular diagnosticsMSArticleIntroduction: Metabolomics, the study of metabolites, is a promising research field for cancers. The metabolic pathway in a tumor cell is different from a normal tissue cell. There are two approaches to study the metabolism, targeted and...
The development of molecular diagnostics in cancer includes careful considerations around the molecular endpoint, the assay specificity, the assay sensitivity, robustness and standardisation. Within the present chapter, the molecular endpoint is a protein and the diagnostic assay includes immunohistochemistry ...
Current research in liquid biopsy diagnostics Using liquid biopsy to screen for cancer and detect treatment response is critical as it can provide in-time information with minimal invasion to the patients [32,33]. The most common fluid obtained in clinical settings is blood. Still, there are als...
Track 5-1: Cancer Biomarkers, Molecular Diagnostics, Blood Tests, and Biopsy. 分会报告5-1:肿瘤生物标记物,分子诊断,血液检测和活检。 microimage.com.cn 6. Whole Genome Amplification Technology, Mutagenic Endonuclease Restriction Assays, and Their Expanding Applications in Molecular Diagnostics 全基因组扩...
and the rate of the approval of targeted cancer therapies remains woefully low. A key challenge and priority in cancer research is therefore to identify molecular biomarkers that could be used to improve early diagnosis, as well as to guide prognosis and the design and monitoring of new therapeut...
molecular diagnostics in the prenatal, oncology, infectious disease, point-of-care, and liquid biopsy fields, plusnew coverageof biomarkers for immunotherapy and companion diagnostics for immuno-oncology. This exciting area has attracted attendance of over 400 delegates to learn what novel technologies,...
molecular diagnosticsnon-invasive biomarkerscirculating tumor DNApersonalized medicineIntroduction: Gastric cancer (GC) is the fifth most common cancer and confers the second-highest mortality among other cancers. Improving the survival rates of GC patients requires prompt and accurate diagnosis and effective...